acebutolol and Thrombocythemia

acebutolol has been researched along with Thrombocythemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evstatiev, R; Gasche, C; Howaldt, S; Kamali, H; Kulnigg-Dabsch, S; Mickisch, O; Schmid, W; Stein, J; Volf, I; Waldhör, T	1
Li, Y; Wang, H; Zhu, W; Zuo, L	1
Gasche, C; Kulnigg-Dabsch, S	1
Bhandari, S; Muñoz, M; Reinisch, W; Staun, M	1

Reviews

1 review(s) available for acebutolol and Thrombocythemia

Article	Year
State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's & colitis, 2013, Volume: 7, Issue:6 Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism	2013

Article

Year

State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease.

Journal of Crohn's & colitis, 2013, Volume: 7, Issue:6

Topics: Algorithms; Anemia, Iron-Deficiency; Clinical Trials as Topic; Diagnosis, Differential; Disaccharides; Dose-Response Relationship, Drug; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Infusions, Intravenous; Iron Deficiencies; Maltose; Prevalence; Thrombocytosis; Thromboembolism

2013

Trials

1 trial(s) available for acebutolol and Thrombocythemia

Article	Year
Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflammatory bowel diseases, 2013, Volume: 19, Issue:8 Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Hepcidins; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Male; Maltose; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Count; Prognosis; Prospective Studies; Thrombocytosis; Young Adult	2013

Article

Year

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.

Inflammatory bowel diseases, 2013, Volume: 19, Issue:8

Topics: Adolescent; Adult; Anemia, Iron-Deficiency; Erythropoietin; Female; Ferric Compounds; Hepcidins; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Male; Maltose; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Count; Prognosis; Prospective Studies; Thrombocytosis; Young Adult

2013

Other Studies

2 other study(ies) available for acebutolol and Thrombocythemia

Article	Year
Iron deficiency generates secondary thrombocytosis and platelet activation in inflammatory bowel disease : the randomized, controlled ThromboVIT trial. Inflammatory bowel diseases, 2013, Volume: 19, Issue:11 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Platelet Activation; Thrombocytosis	2013
Reply to Zuo et al. Inflammatory bowel diseases, 2013, Volume: 19, Issue:11 Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Male; Maltose; Platelet Activation; Thrombocytosis	2013